Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro. Blaisdell A, Zhou Y, Kattah MG, Fisher SJ, et al. Inflamm Bowel Dis 2022;28:1219-1228.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blaisdell A, Zhou Y, Kattah MG, Fisher SJ, et al. Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro. Inflamm Bowel Dis 2022;28:1219-1228.
PMID: 35349682